Gitanjali Jain
Investor Relations Contact chez KEZAR LIFE SCIENCES, INC.
Profil
Gitanjali Jain is currently the VP-Investor Relations & External Affairs at Kezar Life Sciences, Inc. Prior to this, she worked as a Managing Director at Solebury Strategic Communications LLC from 2018 to 2021.
She also held positions as an Associate at StemCells, Inc. from 2000 to 2002 and at Medarex, Inc. from 2002 to 2003.
Ms. Jain completed her undergraduate degree at Brown University and her graduate degree at New York University.
Postes actifs de Gitanjali Jain
| Sociétés | Poste | Début |
|---|---|---|
| KEZAR LIFE SCIENCES, INC. | Investor Relations Contact | 05/10/2021 |
Anciens postes connus de Gitanjali Jain
| Sociétés | Poste | Fin |
|---|---|---|
Solebury Strategic Communications LLC
 Solebury Strategic Communications LLC Miscellaneous Commercial ServicesCommercial Services Solebury Trout LLC engages in communications services. The company is headquartered in the United States. | Corporate Officer/Principal | 01/10/2021 |
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Corporate Officer/Principal | 01/01/2003 |
StemCells, Inc.
 StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | Corporate Officer/Principal | 01/01/2002 |
Formation de Gitanjali Jain
| New York University | Graduate Degree |
| Brown University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| KEZAR LIFE SCIENCES, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Solebury Strategic Communications LLC
Solebury Strategic Communications LLC Miscellaneous Commercial ServicesCommercial Services Solebury Trout LLC engages in communications services. The company is headquartered in the United States. | Commercial Services |
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Commercial Services |
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | Health Technology |